VRDN R&D to Revenue
Viridian Therapeutics Ors Inc · R&D to Revenue
VRDN R&D to Revenue
Latest reported25203.17%period ending
VRDN Quarterly R&D/Revenue (4.01% → 25203.17%)
Latest values, visible window
High-resolution chart · PNG
VRDN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 25,203.169% | |
| 55,057.4468% | |
| 67,581.0606% | |
| 122.2347% | |
| 115,501.3333% | |
| 106,715.2778% | |
| 99,944.4444% | |
| 80,416.2791% | |
| 78,045.8333% | |
| 56,866.6667% | |
| 53,551.3889% | |
| 42,201.3889% | |
| 55,670.8333% | |
| 51,775.5102% | |
| 37,444.7619% | |
| 1,850.9623% | |
| 8,481.25% | |
| 8,215.7407% | |
| 10,464.486% | |
| 3,904.3269% | |
| 1,152.7523% | |
| 951.4817% | |
| 28,248.1481% | |
| 0% | |
| 2,283.3333% | |
| 737.0773% | |
| 956.4773% | |
| 1,298.8489% | |
| 342.0446% | |
| 2,352.4194% | |
| 1,729.8319% | |
| 783.7924% | |
| 383.8222% | |
| 134.051% | |
| 419.2953% | |
| 307.664% | |
| 764.2061% | |
| 891.7749% | |
| 2.7778% | |
| 25.4218% | |
| 38.2151% | |
| 37.5306% | |
| 69.1958% | |
| 50.499% | |
| 26.4305% | |
| 15.5039% | |
| 22.1098% | |
| 5.8582% | |
| 0.7085% | |
| 0.7981% | |
| -7.8256% | |
| 4.7382% | |
| 2.0691% | |
| 4.0147% |